This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.
Executive Summary
- Executive Summary
Market Overview
- Top Ten Specialty Pharmaceutical Companies
- Market Structure
- Research Methodology
Frost & Sullivan Awards
- Growth Strategy Leadership Award
- Market Leadership Award
- Product Line Strategy Award
Teva Pharmaceutical Industries Ltd
Forest Laboratories Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Allergan Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Watson Pharmaceuticals Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Shire Pharmaceuticals Group
- Company Profile
- Product Analysis
- SWOT Analysis
King Pharmaceuticals Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Andrx Corporation
- Company Profile
- Product Analysis
- SWOT Analysis
Barr Pharmaceuticals Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Cephalon Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Endo Pharmaceuticals
- Company Profile
- Product Analysis
- SWOT Analysis
Pharmaceuticals and Biotechnology
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F625-01-00-00-00 |
| Is Prebook | No |
Analysis of Top 10 Specialty Pharmaceutical Companies
Analysis of Top 10 Specialty Pharmaceutical Companies
RELEASE DATE
28-Apr-2006
28-Apr-2006
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: F625-01-00-00-00
SKU: HC01486-NA-MR_06042
$4,950.00
In stock
SKU
HC01486-NA-MR_06042